Physician profile
Ankur Girdhar
NPI 1093964520
$6,779.08
in general payments reported to CMS, 2019-2025
33 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,775 · 2020: $707 · 2021: $310 · 2022: $170 · 2023: $66.79 · 2024: $3,602 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,599 · Travel and Lodging: $733 · Food and Beverage: $485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,599.26 |
| Travel and Lodging | $733.06 |
| Food and Beverage | $485.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,358.12 | 2024 | |
| Glaxosmithkline, LLC. | $590.86 | 2019-2025 | Trelegy Ellipta, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $449.00 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $386.25 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $298.86 | 2019-2022 | |
| Genzyme Corporation | $145.81 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $138.52 | 2021-2024 | Dupixent |
| Bayer Healthcare Pharmaceuticals INC. | $127.58 | 2019-2020 | |
| Inspire Medical Systems, INC. | $124.75 | 2024 | Inspire |
| Genentech USA, INC. | $124.57 | 2019-2021 | |
| United Therapeutics Corporation | $110.59 | 2019-2021 | |
| Grifols USA, LLC | $104.48 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $99.75 | 2019 | |
| Mylan Specialty L.P. | $89.51 | 2019 | |
| Mallinckrodt Enterprises LLC | $81.21 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $59.37 | 2019-2020 | |
| Shire North American Group INC | $50.58 | 2019 | |
| Abbvie INC. | $48.04 | 2021 | |
| Janssen Pharmaceuticals, INC | $47.33 | 2020-2022 | |
| Medical Device Business Services, INC. | $46.02 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $36.45 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.39 | 2022 | |
| Novartis Pharmaceuticals Corporation | $35.01 | 2019 | |
| Philips North America LLC | $30.16 | 2020 | |
| Eisai INC. | $23.86 | 2019 | |
| Advanced Respiratory, INC | $22.57 | 2021 | |
| Pulmonx Corporation | $19.88 | 2024 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Mallinckrodt Hospital Products INC. | $16.89 | 2020 | |
| Resmed Corp | $16.67 | 2019 | |
| Becton, Dickinson and Company | $16.66 | 2025 | Hemosphere |
| Jazz Pharmaceuticals INC. | $15.59 | 2019 | |
| Fisher & Paykel Healthcare INC | $14.20 | 2019 | |
| Allergan, INC. | $13.55 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankur Girdhar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.